MARS an improved de novo peptide candidate selection method for non-canonical antigen target discovery in cancer

Understanding the nature and extent of non-canonical human leukocyte antigen (HLA) presentation in tumour cells is a priority for target antigen discovery for the development of next generation immunotherapies in cancer. We here employ a de novo mass spectrometric sequencing approach with a refined,...

Full description

Bibliographic Details
Main Authors: Liao, H, Barra, C, Zhou, Z, Peng, X, Woodhouse, I, Tailor, A, Parker, R, Carré, A, Borrow, P, Ternette, N, Hogan, MJ, Paes, W, Eisenlohr, LC, Mallone, R, Nielsen, M
Format: Journal article
Language:English
Published: Springer Nature 2024

Similar Items